121 related articles for article (PubMed ID: 35158400)
1. Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study.
Ząbczyk MT; Hanarz M; Malinowski KP; Pociask E; Butenas S; Gajos G; Undas A
Thromb Haemost; 2022 Aug; 122(8):1397-1406. PubMed ID: 35158400
[TBL] [Abstract][Full Text] [Related]
2. Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.
Kusak P; Czarnecka D; Gissel M; Plens K; Butenas S; Undas A
Arch Med Sci; 2016 Oct; 12(5):1000-1007. PubMed ID: 27695490
[TBL] [Abstract][Full Text] [Related]
3. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
[TBL] [Abstract][Full Text] [Related]
4. Markers of NET formation and stroke risk in patients with atrial fibrillation: association with a prothrombotic state.
Mołek P; Ząbczyk M; Malinowski KP; Natorska J; Undas A
Thromb Res; 2022 May; 213():1-7. PubMed ID: 35276507
[TBL] [Abstract][Full Text] [Related]
5. Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.
Paszek E; Pociask E; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2022 Dec; 52(12):e13857. PubMed ID: 35996895
[TBL] [Abstract][Full Text] [Related]
6. Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.
Undas A; Slowik A; Gissel M; Mann KG; Butenas S
Thromb Res; 2011 Nov; 128(5):e62-6. PubMed ID: 21820158
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
[TBL] [Abstract][Full Text] [Related]
8. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
9. Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation.
Mołek P; Chmiel J; Ząbczyk M; Malinowski KP; Natorska J; Undas A
Int J Cardiol; 2022 Oct; 365():1-7. PubMed ID: 35868355
[TBL] [Abstract][Full Text] [Related]
10. Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
Paszek E; Pociask E; Ząbczyk M; Piórkowski A; Butenas S; Legutko J; Undas A
Atherosclerosis; 2022 Apr; 346():124-132. PubMed ID: 35246318
[TBL] [Abstract][Full Text] [Related]
11. Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.
Watson T; Arya A; Sulke N; Lip GY
Chest; 2010 Apr; 137(4):869-76. PubMed ID: 19858230
[TBL] [Abstract][Full Text] [Related]
12. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.
Conway DS; Heeringa J; Van Der Kuip DA; Chin BS; Hofman A; Witteman JC; Lip GY
Stroke; 2003 Feb; 34(2):413-7. PubMed ID: 12574552
[TBL] [Abstract][Full Text] [Related]
15. Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events.
Undas A; Slowik A; Gissel M; Mann KG; Butenas S
Eur J Clin Invest; 2012 Feb; 42(2):123-9. PubMed ID: 21707613
[TBL] [Abstract][Full Text] [Related]
16. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
[TBL] [Abstract][Full Text] [Related]
18. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
[TBL] [Abstract][Full Text] [Related]
19. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
Fu R; Wu S; Wu P; Qiu J
Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292
[TBL] [Abstract][Full Text] [Related]
20. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
Conway DS; Buggins P; Hughes E; Lip GY
J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
